asco lung cancer highlights, pt 12: ganetespib with second line chemotherapy
Published 9 years ago • 91 plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
5:20
asco lung cancer highlights, pt 11: nintedanib with second line chemotherapy
-
2:11
asco lung cancer highlights, pt 13: immune checkpoint inhibitor mpdl3280a in advanced nsclc
-
12:25
adagrasib for previously treated kras g12c nsclc - asco lung review 2022
-
9:49
asco lung cancer highlights, pt 9: the madeit study of predictive biomarkers for chemotherapy
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
8:45
asco lung cancer highlights, part 2: optimizing radiation for stage iii nsclc
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
-
4:42
asco lung cancer roundtable - new combinations chemo immunotherapy for extensive stage sclc
-
8:43
asco lung cancer roundtable - gronberg study - chest radiation with chemo for limited stage sclc
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
13:05
gracecast-009_lung-cancer_the abc's of bac
-
4:02
lung cancer video library - patients with rapid progression through 1st line - receive next?
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
3:46
immunotherapy treatments in patients with head and neck cancer - asco recaps head and neck cancer